Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFGI

British Journal of Cancer

Volumn 86, Issue 6, 2002, Pages 870-878

  Al Yasi, A R ^a   Carroll, M J ^a   Ellison, D ^a   Granowska, M ^a   Mather, S J ^a   Wells, C A ^a   Carpenter, R ^a   Britton, K E ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Axillary node status; Breast cancer; Change detection analysis; Probability mapping; Radiolabelled anti PEM; Radiolabelled humanised monoclonal antibody imaging; Tc 99m hHMFGI

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; MALE; MAMMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECOND CANCER;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST; BREAST NEOPLASMS; CA-15-3 ANTIGEN; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; RADIOIMMUNODETECTION; TECHNETIUM;

EID: 0037128664     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600200     Document Type: Article

References (25)

1. Statistical parametric mapping in functional neuroimaging: Beyond PET and fMRI activation studies
2. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein
3. Assessment of axillary lymph node involvement in breast cancer. Patients with positron emission tomography using radiolabeled 2 (fluorine 18)-fluoro-2 deoxy-D-glucose
4. Tc-99m labelled SM3 in the pre-operative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection
5. Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can PET with 18F-FDG be considered as the best methods?
6. Radioimmunoscintigraphy in tumour identification
7. Development and characterisation of breast cancer reactive monoclonal antibodies directed to the coreprotein of the human milk mucin
8. Effect of modification of the carbohydrate side chains in the reactivity of antibodies with core protein epitopes
9. Prospective evaluation of F18-FDG PET in presurgical staging of the axilla in breast cancer
10. Targeting of Iodine-123-labeled tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours
11. Reshaping a therapeutic CD4 antibody
12. Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy
13. Replacing the complementarity-determining regions in a human antibody with those from a mouse
14. The sentinel node in breast cancer - A multicentre validation study
15. Reduction mediated Technetium-99m labelling of monoclonal antibodies
16. Reshaping human antibodies: Grafting antilysozyme activity
17. Recent results in cancer research
18. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation
19. Monoclonal antibodies to epithelium specific components of human milk fat globule: Production and reaction with cells in culture
20. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in staging of the axilla related to surgery and immunocytochemistry
21. Construction of a reshaped HMFG1 antibody and comparison of its fine specificity with that of the parent mouse antibody
22. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
23. Initial evaluation of FDG PET for the staging of the axilla in newly-diagnosed breast carcinoma patients
24. A transgenic mouse model for tumour immunotherapy: Induction of an anti-idiotype response to human MUC1